title: Combining tiotropium and salmeterol in COPD: Effects on airflow obstruction and symptoms.
authors.affiliation: Department of Respiratory Diseases, Atrium medisch centrum, Henri Dunantstraat 5, 6419 PC Heerlen, The Netherlands. j.a.vannoord@atriummc.nl
authors.forename: J A
authors.initials: JA
authors.lastname: van Noord
authors.forename: J-L
authors.initials: JL
authors.lastname: Aumann
authors.forename: E
authors.initials: E
authors.lastname: Janssens
authors.forename: J J
authors.initials: JJ
authors.lastname: Smeets
authors.forename: J
authors.initials: J
authors.lastname: Zaagsma
authors.forename: A
authors.initials: A
authors.lastname: Mueller
authors.forename: P J G
authors.initials: PJ
authors.lastname: Cornelissen
mesh_terms: D000328:Adult; D000402:Airway Obstruction / Q000188:drug therapy* / Q000503:physiopathology; D000420:Albuterol / Q000008:administration & dosage / Q000031:analogs & derivatives*; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D018592:Cross-Over Studies; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D004417:Dyspnea / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy* / Q000503:physiopathology; D000068299:Salmeterol Xinafoate; D012602:Scopolamine Derivatives / Q000008:administration & dosage*; D013147:Spirometry; D000069447:Tiotropium Bromide; D016896:Treatment Outcome
chemical_list: D001993:Bronchodilator Agents; D012602:Scopolamine Derivatives; D000068299:Salmeterol Xinafoate; D000420:Albuterol; D000069447:Tiotropium Bromide